Sensyne Health app technology to be used in University of Oxford COVID-19 test evaluation

0 35

Sensyne Health PLC (LON:SENS) has said the University of Oxford is deploying the company’s app in a new coronavirus (COVID-19) clinical study.

CVm-Health+ will be used in the FACTS evaluation of the feasibility and acceptability of new point-of-care tests for regular asymptomatic COVID-19 testing in the community.

The Sensyne technology, which will be available to iPhone and Android users, will provide access to study information and links to training materials.

It will also record the health status and test result data for students and staff and capture a time-stamped photograph of the test result every time one is carried out.

“The COVID-19 pandemic is forcing all organisations to understand and adapt to infection risk,” said Sensyne chief executive Lord Drayson in a statement.

“Remote health monitoring software and the analysis of health data using clinical AI is already helping to mitigate the effects of COVID-19 in the healthcare sector and we are pleased that  CVm-Health is being used for another clinical study of national importance.”

Leave A Reply

Your email address will not be published.